Inovio Pharmaceuticals Inc. (INO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Inovio Pharmaceuticals In...

    NASDAQ: INO · Real-Time Price · USD
    2.79
    0.04 (1.45%)
    At close: Sep 05, 2025, 3:59 PM
    2.85
    2.15%
    After-hours: Sep 05, 2025, 07:38 PM EDT

    Inovio Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 65.81M 14.31M 46.33M 71.14M
    Short-Term Investments
    		 28.3M 130.98M 206.67M 330.17M
    Long-Term Investments
    		 1.61M 2.78M 2.01M 3.91M
    Other Long-Term Assets
    		 3.68M 605.32K 684.04K 1.43M
    Receivables
    		 1.2M 2.41M 11.74M 8.03M
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 n/a 20.43K 30.38M 261.19K
    Total Current Assets
    		 97.83M 153.11M 315.24M 448.44M
    Property-Plant & Equipment
    		 11.77M 14.45M 17.96M 29.02M
    Goodwill & Intangibles
    		 n/a n/a 12.64M 13.14M
    Total Long-Term Assets
    		 17.07M 17.84M 33.29M 47.5M
    Total Assets
    		 113.2M 170.95M 348.53M 495.94M
    Account Payables
    		 6.44M 4.65M 21.08M 27.97M
    Deferred Revenue
    		 n/a n/a n/a 21.63K
    Short-Term Debt
    		 2.5M 16.77M 2.8M 2.6M
    Other Current Liabilities
    		 23.89M 9.95M 12.33M 18.11M
    Total Current Liabilities
    		 35.33M 42.57M 96.87M 65.74M
    Long-Term Debt
    		 n/a n/a 16.61M 14.96M
    Other Long-Term Liabilities
    		 n/a n/a -16.61M 14.83K
    Total Long-Term Liabilities
    		 9.37M 11.03M 29.3M 30.53M
    Total Liabilities
    		 44.69M 53.6M 126.17M 96.27M
    Total Debt
    		 11.87M 30.21M 32.07M 33.02M
    Common Stock
    		 36.1K 22.79K 253.09K 217.38K
    Retained Earnings
    		 -1.73B -1.62B -1.49B -1.21B
    Comprehensive Income
    		 -675.67K -662.6K -698.74K -282.24K
    Shareholders Equity
    		 68.5M 117.35M 222.36M 399.67M
    Total Investments
    		 29.91M 133.76M 208.68M 334.08M

    Add to Watchlist